Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M-Share Biotech (Shanghai Meixiang Biological Technology) is a specialized provider of life science research tools and bioprocessing solutions based in Shanghai, China. The company focuses on the development and manufacturing of high-quality cell culture media, including serum-free and chemically defined formulations for CHO, HEK293, and various immune cell lines. M-Share Biotech serves the biopharmaceutical industry by providing essential raw materials and technical services for the production of monoclonal antibodies, recombinant proteins, and cell and gene therapies. Their offerings include customized media optimization, large-scale manufacturing, and a comprehensive range of laboratory reagents and consumables. The company aims to support the localization of high-end bioprocessing materials to improve efficiency and reduce costs for global biotech firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 美享生物科技.